Deerfield Management Company, L.P.

Institutional investor · Portfolio as of Q4 2019

Q4 2019 Summary

First quarter we have for this fund: 76 positions, nothing earlier to compare. Portfolio: $3.1B across 76 positions.

Top Holdings76 positions

Checking export access…
Activity:
144.8M$191.5M6.1%——
1 qtr
First report
0
AHCO

AdaptHealth Corp.

17.2M$188.9M6.0%$10.980.00%
1 qtr
First report
0
HZNP
HZNPDelisted

HORIZON THERAPEUTICS PUB L

4.7M$171.7M5.5%——
1 qtr
First report
0
MYL
MYLDelisted

MYLAN NV

8.2M$163.9M5.2%——
1 qtr
First report
0
??
NEVRO CORPDelisted
Bond
115.8M$154.3M4.9%——
1 qtr
First report
0
ORTX
ORTXDelisted
ADR

ORCHARD THERAPEUTICS PLC

8.9M$121.9M3.9%——
1 qtr
First report
0
5.2M$108.6M3.5%——
1 qtr
First report
0
RYTM

Rhythm Pharmaceuticals, Inc.

4.3M$98.5M3.1%$22.960.00%
1 qtr
First report
0
MIRM

Mirum Pharmaceuticals, Inc.

3.4M$84.6M2.7%$24.520.00%
1 qtr
First report
0
TNDM

Tandem Diabetes Care, Inc.

1.4M$81.2M2.6%$59.610.00%
1 qtr
First report
0
XLRN

ACCELERON PHARMA INC

1.4M$72.6M2.3%——
1 qtr
First report
0
RARX
RARXDelisted

RA PHARMACEUTICALS

1.5M$71.3M2.3%——
1 qtr
First report
0
CNC

Centene Corporation

1.1M$69.7M2.2%$62.870.00%
1 qtr
First report
0
XENT
XENTDelisted

INTERSECT ENT INC

2.8M$69.6M2.2%——
1 qtr
First report
0
??
INTERCEPT PHARMASDelisted
Bond
57.8M$58.3M1.9%——
1 qtr
First report
0
MYOK
MYOKDelisted

MYOKARDIA INC

789,000$57.5M1.8%——
1 qtr
First report
0
ARDX

Ardelyx, Inc.

7M$52.6M1.7%$7.510.00%
1 qtr
First report
0
BKD

Brookdale Senior Living Inc.

7.2M$52.5M1.7%$7.270.00%
1 qtr
First report
0
SILK
SILKDelisted

SILK ROAD MEDICAL INC

1.3M$51.7M1.6%——
1 qtr
First report
0
DBVT
DBVT
ADR

DBV Technologies S.A.

4.8M$50.9M1.6%$21.400.00%
1 qtr
First report
0
$3.1B
AUM
76
Positions
Q4 2019
Filing
HI rating · 1.0/5
Quarterly 13F Value Change
Not enough history yet
Activity profile
Q4'19

First report: nothing earlier to compare

Composition
Equity vs derivatives
Equity>99%Puts<1%Calls0%
Holding period
<1Q100%1-4Q0%1-2Y0%2Y+0%

Deerfield Management Company, L.P. manages $3.1B across 76 positions as of Q4 2019. Top holdings: HORIZON PHARMA INV LTD (6.1%), AHCO (6.0%), HZNP (5.5%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 1/5.0.

Top holdings by portfolio weight

Total AUM$3B
HORIZON PHAR6.11%
AHCO6.03%
HZNP5.48%
MYL5.23%
NEVRO CORP4.92%
ORTX3.89%
HOMOLOGY MED3.46%
RYTM3.14%
MIRM2.70%
TNDM2.59%
Other2.32%

Portfolio allocation by GICS sector

Sectors3
Healthcare49.88%
Unknown49.33%
Financial Services0.79%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Healthcare, Unknown
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Weak(1.0 / 5.0)
Holdings P&L32
Conviction55
Concentration66
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Top Losers

Checking access…

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
BCRXBCRXBioCryst Pharmaceuticals, Inc.
Q3 2025 → Q3 2026+10.8M shares+$87M
3Q
TNGXTNGXTango Therapeutics, Inc.
Q1 2026 → Q3 2026+2.3M shares+$103.5M
2Q
BMRNBMRNBioMarin Pharmaceutical Inc.
Q2 2026 → Q3 2026+1.2M shares+$73.4M
Checking access…

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Photo credits

Photo:“Warren Buffett at the 2015 SelectUSA Investment Summit”by USA International Trade Administration, cropped,public domainvia Wikimedia Commons

Photo:Leopold Aschenbrenner

Photo:“Cathie Wood ARK Invest Photo”by Caroline Wood, cropped,CC BY-SA 4.0via Wikimedia Commons

Photo:“Valeant Pharmaceuticals' Business Model (headshot)”by Senate Democrats, cropped,CC BY 2.0via Wikimedia Commons

Photo:Harlem Children's Zone

Photo:Mohnish Pabrai

Photo:“Peter Thiel on March 5 2026”by Kantei (The Prime Minister Office of Japan), cropped,CC BY 4.0via Wikimedia Commons

Photo:Charlotte FC

Photo:Ray Dalio

Photo:Himalaya Capital

Photo:Jonathan Kozowyk, Robin Hood

Photo:“Brad Gerstner at the White House 2025 (54581192563)”by The White House, cropped,public domainvia Wikimedia Commons

Photo:SuperReturn North America

Photo:Liz Linder, Harvard Kennedy School

Photo:Oaktree Capital Management

Photo:The Everglades Foundation

Photo:George Soros

Photo:Benjamin Meaker, Point72

Photo:Fundsmith

Photo:“Kenneth C. Griffin photo”by Paul Elledge, cropped,CC BY-SA 4.0via Wikimedia Commons

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used